Literature DB >> 16444857

Effects of local gene transfer of VEGF on neointima formation after balloon injury in hypercholesterolemic rabbits.

Jozef Dulak1, Severin P Schwarzacher, Ralf H Zwick, Hannes Alber, Gunda Millonig, Caecilia Weiss, Heike Hügel, Matthias Frick, Alicja Jozkowicz, Otmar Pachinger, Franz Weidinger.   

Abstract

Enhancement of the generation of nitric oxide (NO) and vascular endothelial growth factor (VEGF) are suggested to prevent restenosis after angioplasty. Accordingly, we tested whether the local delivery of L-arginine (L-Arg), a substrate for NO generation and the VEGF gene, alone or in combination, can influence neointima formation in hypercholesterolemic rabbits. Balloon injury of the iliac arteries was performed in 24 New Zealand White rabbits fed a 1% cholesterol diet for 3 weeks followed by a local infusion of: (1) pSG5VEGF165 plasmid alone (1000 microg); (2) pSG5VEGF165 (1000 microg) with L-Arg (800mg); (3) L-Arg (800mg) alone; and (4) L-Arg (800 mg) with naked pSVbeta-gal plasmid (1000 microg). The animals were kept on the hypercholesterolemic diets for a further 28 days, when vessels were taken for morphometric analysis and immunocytochemistry. Endogenous rabbit VEGF concentration in the plasma increased significantly at 7 days after injury (17.06 +/- 1.57 vs 23.01 +/- 1.9 pg/ml; p < 0.02) and remained elevated for up to 28 days (28.46 +/- 5.24; p < 0.01). Injured arteries exhibited strong immunocytochemical staining for rabbit VEGF. Rabbits that received a VEGF gene transfer revealed more prominent neointima formation, whereas treatment with L-Arg was associated with significantly less intimal thickness (p < 0.05). Local transfer of the VEGF gene does not inhibit neointima formation in hypercholesterolemic rabbits. Our results suggest that VEGF gene therapy applied locally in atherosclerotic arteries may not be beneficial.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16444857      PMCID: PMC1391925          DOI: 10.1191/1358863x05vm630oa

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  41 in total

1.  Vascular endothelial growth factor (VEGF) expression during arterial repair in the pig.

Authors:  S J Wysocki; M H Zheng; A Smith; P E Norman
Journal:  Eur J Vasc Endovasc Surg       Date:  1998-03       Impact factor: 7.069

2.  VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries.

Authors:  M Laitinen; I Zachary; G Breier; T Pakkanen; T Häkkinen; J Luoma; H Abedi; W Risau; M Soma; M Laakso; J F Martin; S Ylä-Herttuala
Journal:  Hum Gene Ther       Date:  1997-10-10       Impact factor: 5.695

3.  Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor.

Authors:  C J Magovern; C A Mack; J Zhang; T K Rosengart; O W Isom; R G Crystal
Journal:  Hum Gene Ther       Date:  1997-01-20       Impact factor: 5.695

4.  Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty.

Authors:  S P Schwarzacher; T T Lim; B Wang; R S Kernoff; J Niebauer; J P Cooke; A C Yeung
Journal:  Circulation       Date:  1997-04-01       Impact factor: 29.690

5.  Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

Authors:  M Ziche; L Morbidelli; R Choudhuri; H T Zhang; S Donnini; H J Granger; R Bicknell
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

6.  N(G)-nitro-L-arginine- and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia.

Authors:  R P Brandes; A Behra; C Lebherz; R H Böger; S M Bode-Böger; L Phivthong-Ngam; A Mügge
Journal:  Atherosclerosis       Date:  1997-11       Impact factor: 5.162

7.  Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.

Authors:  H Miyazaki; H Matsuoka; J P Cooke; M Usui; S Ueda; S Okuda; T Imaizumi
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

8.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.

Authors:  T Murohara; T Asahara; M Silver; C Bauters; H Masuda; C Kalka; M Kearney; D Chen; J F Symes; M C Fishman; P L Huang; J M Isner
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis.

Authors:  M Inoue; H Itoh; M Ueda; T Naruko; A Kojima; R Komatsu; K Doi; Y Ogawa; N Tamura; K Takaya; T Igaki; J Yamashita; T H Chun; K Masatsugu; A E Becker; K Nakao
Journal:  Circulation       Date:  1998-11-17       Impact factor: 29.690

10.  Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions.

Authors:  M A Ramos; M Kuzuya; T Esaki; S Miura; S Satake; T Asai; S Kanda; T Hayashi; A Iguchi
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-07       Impact factor: 8.311

View more
  5 in total

1.  Inhibition of intimal hyperplasia via local delivery of vascular endothelial growth factor cDNA nanoparticles in a rabbit model of restenosis induced by abdominal aorta balloon injury.

Authors:  Hongzhi Xie; Jing Yang; Yechen Han; Xueqing Zhu; Quan Fang
Journal:  Exp Ther Med       Date:  2015-04-21       Impact factor: 2.447

Review 2.  The Sleeping Beauty transposon system: a non-viral vector for gene therapy.

Authors:  Elena L Aronovich; R Scott McIvor; Perry B Hackett
Journal:  Hum Mol Genet       Date:  2011-04-01       Impact factor: 6.150

Review 3.  Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.

Authors:  Zsuzsanna Izsvák; Perry B Hackett; Laurence J N Cooper; Zoltán Ivics
Journal:  Bioessays       Date:  2010-09       Impact factor: 4.345

4.  ATF-4 and vascular injury: integration of growth factor signaling and the cellular stress response.

Authors:  Michael T Chin
Journal:  Circ Res       Date:  2008-08-15       Impact factor: 17.367

5.  Human hepatocyte growth factor inhibits early neointima formation in rabbit abdominal aortae following ultrasound-guided balloon injury.

Authors:  Li Mei; Yu He; Hui Wang; Ying Jin; Shuai Wang; Chunxiang Jin
Journal:  Mol Med Rep       Date:  2017-08-11       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.